Jonas C. S. Bergh
Karolinska University Hospital · 937 works · 73,079 citations · h-index 104
Top works
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
- Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
- Pembrolizumab for Early Triple-Negative Breast Cancer
- 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
- Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
- Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
- Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
- Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: Five-Year Results of a Randomized Trial
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
- 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
- Identification of molecular apocrine breast tumours by microarray analysis